Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04253834 · ClinicalTrials.gov registry record · NA

GO2 PEEP Study: Bidirectional Oxygenation Valve in Postoperative Atelectasis

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT04253834: Completed NA study, sponsored by Emory University.

NCT04253834 is a NA study that has completed, run by Emory University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04253834, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This study compares a novel breathing device, called the GO2 Mouthpiece, to the standard breathing tool called the incentive spirometer, thus improving respiratory dynamics of the postoperative patient.

Primary Outcome

Partial pressure of oxygen is a measurement of oxygen pressure in arterial blood. It reflects how well oxygen is able to move from the lungs to the blood. Normal values are 80 to 100 millimeters of mercury (mmHg).

Interventions

  • DEVICE Incentive spirometer
  • DEVICE GO2 Mouthpiece

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2020-08-27
Est. Completion 2021-01-31
Phase NA
Emory University

1,208 total trials

What the finished NCT04253834 record still lists

NCT04253834 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Incentive spirometer is the first listed.

NCT04253834 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04253834 about?

NCT04253834 is a clinical study titled "GO2 PEEP Study: Bidirectional Oxygenation Valve in Postoperative Atelectasis". This study compares a novel breathing device, called the GO2 Mouthpiece, to the standard breathing tool called the incentive spirometer, thus improving respiratory dynamics of the postoperative patient.

What is the current status of trial NCT04253834?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-08-27. Estimated completion is 2021-01-31.

What interventions are being tested in trial NCT04253834?

The interventions under investigation include: Incentive spirometer (DEVICE), GO2 Mouthpiece (DEVICE).

Who is sponsoring clinical trial NCT04253834?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04253834's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04253834, the US trial registry maintained by the National Library of Medicine. NCT04253834 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.